| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0076 | 0.9 |